Innovative Medical: Announcement of Abnormal Stock Trading Fluctuations
Securities Code: 002173 Securities Abbreviation: Innovative Medical Announcement Number: 2026-033
Innovative Medical Management Co., Ltd.
Announcement on abnormal stock trading fluctuations
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and that there are no false records, misleading statements or major omissions.
1. Introduction to abnormal stock trading fluctuations
The daily closing price increase deviation of the stock of Innovative Medical Management Co., Ltd. (hereinafter referred to as the "Company") (stock abbreviation: Innovative Medical, stock code: 002173) for three consecutive trading days on July 16, 17, and 20, 2026, accumulated by more than 20%. According to the relevant provisions of the "Shenzhen Stock Exchange Trading Rules", the company's stock is subject to abnormal trading fluctuations.
2. Explanation of the company’s attention and verification
In response to the abnormal fluctuations in the company's stock trading, the company has verified the controlling shareholders and actual controllers, the company's directors and senior managers on relevant issues. The relevant situation is now explained as follows:
There is no need to correct or supplement the information previously disclosed by the company.
The company is not aware of recent public media reports on undisclosed major information that may or has had a greater impact on the company's stock trading price.
There have been no major changes in the company’s production and operation conditions and internal and external operating environment recently.
There are no major matters that should be disclosed but have not been disclosed by the company, controlling shareholders and actual controllers, nor are there any undisclosed major matters that are in the planning stage.
The company has no other violations of fair information disclosure regulations.
The company’s controlling shareholder and actual controller did not buy or sell the company’s stocks during the period of abnormal fluctuations in the company’s stock trading.
3. Whether there is an explanation of information that should be disclosed but has not been disclosed
The company's board of directors confirmed that the company currently has no undisclosed matters that should be disclosed in accordance with the "Shenzhen Stock Exchange Stock Listing Rules" and other relevant regulations, or plans, negotiations, intentions, agreements, etc. related to the matter;
1/2
The board of directors is also not informed that the company has other undisclosed information that should be disclosed in accordance with relevant regulations such as the "Shenzhen Stock Exchange Stock Listing Rules" and has a greater impact on the trading price of the company's stocks and its derivatives; there is no need to correct or supplement the information disclosed in the company's previous period.
4. Risk warning
The company has not violated the fair disclosure of information after self-examination.
The company disclosed the "2026 Semi-annual Performance Forecast" (announcement number: 2026-032) on the cninfo.com (https://www.cninfo.com.cn) on July 15, 2026. As of the date of this announcement, the company has no need to revise its 2026 semi-annual performance forecast. This performance forecast is the result of preliminary calculations by the company's financial department. Specific financial data will be disclosed in detail in the company's 2026 semi-annual report. Investors are advised to pay attention to investment risks.
The company solemnly reminds investors that the company’s current designated media for information disclosure are Securities Times, Shanghai Securities News, Securities Daily, China Securities Journal and the Cninfo Network (http://www.cninfo.com.cn). All the company’s information is subject to the information published in the above designated media. Investors are requested to invest rationally and pay attention to investment risks.
Announcement is hereby made.
Board of Directors of Innovative Medical Management Co., Ltd.
July 21, 2026
2/2